Trial intelligence / Profile preview

CoolXenon2: Xenon plus therapeutic hypothermia in term neonates after hypoxic-ischaemic insult

2011-005397-34Phase 2Completed

Sponsor
University Hospitals Bristol and Weston NHS Foundation Trust
Start
Feb 2012
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of xenon in Neonatal hypoxic-ischemic encephalopathy (HIE), hypoxia, sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Started Feb 2012; status: completed.

02

Drugs

xenon
03

Conditions

Neonatal hypoxic-ischemic encephalopathy (HIE)hypoxia

Beyond the preview

Go deeper on 2011-005397-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005397-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call